WilliamJayHymanMDFACP

PubMed

• 39 citations
  A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia
  Craig W. Reynolds, Nicholas J. Di Bella, Roger M. Lyons, William J. Hyman, Donald A. Richards, Gerald J. Robbins, Mark Vellek, Kristi A. Boehm, Feng Zhan, Lina Asmar> ;Investigational New Drugs. 2012 Jun 1
• 11 citations
  Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer
  Donald A. Richards, David M. Loesch, Svetislava J. Vukelja, Hillary H. Wu, William J. Hyman, Jeffery Nieves, Yunfei Wang, Simin Hu, Oluwatoyin O. Shonukan, Datchen F. Tai> ;Investigational New Drugs. 2011 Oct 1
• Randomized phase II study of perifosine in combination with capecitabine versus capecitabine alone in patients with second- or third-line metastatic colon cancer.
  Vukelja S, Richards D, Campos LT, Bedell C, Hagenstad C, Hyman W, Letzer J, Gardner L, Sportelli P, Nemunaitis J> ;J. Clin. Oncol.. 2009-05-20
• Phase I study of pemetrexed (P) and pegylated liposomal doxorubicin (PLD) in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer.
  Richards DA, Loesch D, Vukelja SJ, Wu HH, Hyman WJ, Nieves J, Wang Y, Hu S, Shonukan O, Tai D> ;J. Clin. Oncol.. 2009-05-20
• 396 citations
  Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research...
  Stephen E. Jones, Frankie A. Holmes, Joyce O'Shaughnessy, Joanne L. Blum, Svetislava J. Vukelja, Kristi J. McIntyre, John Pippen, James H. Bordelon, Robert Kirby, John...> ;Journal of Clinical Oncology. 2009 Mar 10
• 10 citations
  Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.
  Thomas H. Cartwright, Paul R. Kuefler, Allen Lee Cohn, William J. Hyman, Maury Berger, Donald A. Richards, Svetislava J. Vukelja, John E. Nugent, Robert L. Ruxer, Kris...> ;Clinical Colorectal Cancer. 2008 Nov 1
• 381 citations
  Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer
  Stephen E. Jones, Michael Savin, Frankie A. Holmes, Joyce O'Shaughnessy, Joanne L. Blum, Svetislava J. Vukelja, Kristi J. McIntyre, John Pippen, James H. Bordelon, Rob...> ;Journal of Clinical Oncology. 2006 Dec 1
• Results of a phase II trial of cetuximab+XELIRI as first-line therapy of patients with advanced and/or metastatic colorectal cancer.
  Cartwright TH, Kuefler P, Cohn A, Hyman W, Boehm KA, Ilegbodu D, Asmar L> ;J. Clin. Oncol.. 2006-06-20
• Results of a pilot trial of OSI-461 in patients with chronic lymphocytic leukemia.
  Reynolds CH, Raju RN, Vukelja SJ, Belt RJ, Hyman WJ, Boehm KA, Asmar L> ;J. Clin. Oncol.. 2004-07-15
• A phase II trial of gemcitabine and carboplatin (GC) in patients with transitional cell carcinoma of the urinary tract (TCC).
  Olivares J, Hyman W, Senzer N> ;J. Clin. Oncol.. 2004-07-15
• 10 citations
  Results of a Phase II Multicenter Trial of Pentostatin and Rituximab in Patients with Low-Grade B-Cell Non-Hodgkin's Lymphoma: An Effective and Minimally Toxic Regimen
  Robert Drapkin, Nicholas J. Di Bella, David C. Faragher, Elizabeth Harden, Carmen Matei, William J. Hyman, Mae Y. Mirabel, Kristi A. Boehm, Lina Asmar> ;Clinical Lymphoma. 2003 Dec 1
• 45 citations
  Cellular Immune Profile of Patients With Advanced Cancer Before and After Taxane Treatment
  Alex W. Tong, B. Seamour, J. M. Lawson, G. Ordonez, S. Vukelja, William J. Hyman, Donald A. Richards, L. Stein, P. B. Maples, John Nemunaitis> ;American Journal of Clinical Oncology. 2000 Oct 1
• 4 citations
  Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Hematopoietic Growth Factor PIXY321 After Moderate-Dose Fluorouracil, Doxorubicin, and Cyclophospham...
  Stephen E. Jones, Pankaj Khandelwal, Kristi J. McIntyre, Robert G. Mennel, Douglas Orr, Robert Kirby, Edward Agura, Lewis Duncan, William J. Hyman, Tammy Roque, David ...> ;Journal of Clinical Oncology. 1999 Oct 1
• 1 citations
  SK&F107647 : A synthetic hematoregulatory peptide in patients with solid tumor malignancies: A Phase I trial
  John Nemunaitis, David E. Martin, Deborah L. Willis, Martin I. Freed, Blanche Levitt, Donald A. Richards, John Cox, Gary T. Kimmel, William J. Hyman, Diane K. Jorkasky> ;American Journal of Clinical Oncology. 1998 Apr 1
• Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance o...
  Crucitt, M. A., Hyman, W., Grote, T., Tester, W., Madajewicz, S., Yee, S., Wentz, A., Griffin, D., Parasuraman, T. V., Bryson, J.> ;Clin Ther. 1996 Jul 01
• Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance o...
  Crucitt, M. A., Hyman, W., Grote, T., Tester, W., Madajewicz, S., Yee, S., Wentz, A., Griffin, D., Parasuraman, T. V., Bryson, J.> ;Clin Ther. 1996 May 01
• Exfoliative cytology of the canine urinary bladder: a technique utilising Millipore filtration.
  Rozengurt, N., Hyman, W. J., Berry, A., Cooper, J. E., Wedderburn, N.> ;Vet Rec. 1985 Apr 13
• Urinary cytology of a canine bladder carcinoma.
  Rozengurt, N., Hyman, W. J., Berry, A., Cooper, J. E., Wedderburn, N.> ;J Comp Pathol. 1986 Sep 01
• Join now to see all